These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay. Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440 [TBL] [Abstract][Full Text] [Related]
6. From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules. Woodland A; Grimaldi R; Luksch T; Cleghorn LA; Ojo KK; Van Voorhis WC; Brenk R; Frearson JA; Gilbert IH; Wyatt PG ChemMedChem; 2013 Jul; 8(7):1127-37. PubMed ID: 23776181 [TBL] [Abstract][Full Text] [Related]
7. Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors. Hutton JA; Goncalves V; Brannigan JA; Paape D; Wright MH; Waugh TM; Roberts SM; Bell AS; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW J Med Chem; 2014 Oct; 57(20):8664-70. PubMed ID: 25238611 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors. Li Z; Xin W; Wang Q; Zhu M; Zhou H Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors. Xin W; Li Z; Wang Q; Du J; Zhu M; Zhou H Eur J Med Chem; 2020 Jan; 185():111827. PubMed ID: 31732256 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs. Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171 [TBL] [Abstract][Full Text] [Related]
11. Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase. Robinson DA; Wyatt PG Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):586-93. PubMed ID: 25945713 [TBL] [Abstract][Full Text] [Related]
12. Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. Brand S; Norcross NR; Thompson S; Harrison JR; Smith VC; Robinson DA; Torrie LS; McElroy SP; Hallyburton I; Norval S; Scullion P; Stojanovski L; Simeons FR; van Aalten D; Frearson JA; Brenk R; Fairlamb AH; Ferguson MA; Wyatt PG; Gilbert IH; Read KD J Med Chem; 2014 Dec; 57(23):9855-69. PubMed ID: 25412409 [TBL] [Abstract][Full Text] [Related]
13. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design. Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313 [TBL] [Abstract][Full Text] [Related]
14. A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors. Harrison JR; Brand S; Smith V; Robinson DA; Thompson S; Smith A; Davies K; Mok N; Torrie LS; Collie I; Hallyburton I; Norval S; Simeons FRC; Stojanovski L; Frearson JA; Brenk R; Wyatt PG; Gilbert IH; Read KD J Med Chem; 2018 Sep; 61(18):8374-8389. PubMed ID: 30207721 [TBL] [Abstract][Full Text] [Related]
15. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine. Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610 [TBL] [Abstract][Full Text] [Related]
16. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major. Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339 [TBL] [Abstract][Full Text] [Related]
18. Novel Thienopyrimidine Inhibitors of Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985 [TBL] [Abstract][Full Text] [Related]
19. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors. Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141 [TBL] [Abstract][Full Text] [Related]
20. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis. Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]